Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

PURPOSE: To assess the incidence of BCR‐ABL kinase domain (KD) mutation detection and its prognostic significance in chronic phase chronic myeloid leukemia (CP‐CML) patients treated with tyrosine kinase inhibitors (TKIs). PATIENTS AND METHODS: We analyzed characteristics and outcome of 253 CP‐CML pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Etienne, Gabriel, Dulucq, Stéphanie, Huguet, Françoise, Schmitt, Anna, Lascaux, Axelle, Hayette, Sandrine, Fort, Marie‐Pierre, Sujobert, Pierre, Bijou, Fontanet, Morisset, Stéphane, Tavitian, Suzanne, Bidet, Audrey, Turcq, Beatrice, Robbesyn, Fanny, Chollet, Claudine, Belloc, Francis, Durrieu, Françoise, Mahon, François‐Xavier, Nicolini, Franck E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718576/
https://www.ncbi.nlm.nih.gov/pubmed/31350815
http://dx.doi.org/10.1002/cam4.2410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718576/
https://www.ncbi.nlm.nih.gov/pubmed/31350815
http://dx.doi.org/10.1002/cam4.2410

Ejemplares similares